Company Filing History:
2 out of 67 
1 out of 77 
Years Active: 2008-2009
Title: Olli Taneli Pentikaeinen: Innovator in Therapeutic Compounds
Introduction
Olli Taneli Pentikaeinen is a notable inventor based in Lieto, Finland. He has made significant contributions to the field of therapeutic compounds, particularly in the treatment of steroid hormone-dependent diseases. With a total of two patents to his name, Pentikaeinen's work is recognized for its potential impact on medical therapies.
Latest Patents
Pentikaeinen's latest patents focus on Thiophenepyrimidinone compounds and their use in therapy. These compounds are particularly relevant for the treatment and prevention of steroid hormone-dependent diseases or disorders. His innovative approach includes the inhibition of 17β-hydroxysteroid dehydrogenase enzymes, which plays a crucial role in these medical conditions.
Career Highlights
Throughout his career, Pentikaeinen has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Solvay Pharmaceuticals, B.V. and Solvay Pharmaceuticals, GmbH. His experience in these organizations has contributed to his expertise in developing therapeutic solutions.
Collaborations
Pentikaeinen has collaborated with several professionals in his field, including Leena Hirvelae and Nina Johansson. These partnerships have likely enhanced his research and development efforts, leading to innovative therapeutic solutions.
Conclusion
Olli Taneli Pentikaeinen is a distinguished inventor whose work in therapeutic compounds has the potential to transform treatment options for steroid hormone-dependent diseases. His contributions to the field are noteworthy and reflect his commitment to advancing medical science.